Literature DB >> 9195109

Shiga toxin-producing Escherichia coli serotype OX3:H21 as a cause of hemolytic-uremic syndrome.

M Keskimäki1, R Ikäheimo, P Kärkkäinen, F Scheutz, Y Ratiner, R Puohiniemi, A Siltonen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9195109     DOI： 10.1086/513668

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  15 in total

1.  Presence of activatable Shiga toxin genotype (stx(2d)) in Shiga toxigenic Escherichia coli from livestock sources.

Authors:  Kari S Gobius; Glen M Higgs; Patricia M Desmarchelier
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

2.  Shiga toxin-producing Escherichia coli in finland from 1990 through 1997: prevalence and characteristics of isolates.

Authors:  M Keskimäki; M Saari; T Heiskanen; A Siitonen
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

3.  Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype.

Authors:  M Eklund; F Scheutz; A Siitonen
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

4.  Heterogeneity of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients, cattle, and food samples in central France.

Authors:  N Pradel; K Boukhors; Y Bertin; C Forestier; C Martin; V Livrelli
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

5.  Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles.

Authors:  Marjut Eklund; Kirsikka Leino; Anja Siitonen
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga Toxin-producing E. coli in stool samples.

Authors:  Patrick J Gavin; Lance R Peterson; Anna C Pasquariello; Joanna Blackburn; Mark G Hamming; Kuo J Kuo; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Non-O157:H7 Stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic-uremic syndrome in adults.

Authors:  R Bonnet; B Souweine; G Gauthier; C Rich; V Livrelli; J Sirot; B Joly; C Forestier
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period.

Authors:  Lothar Beutin; Gladys Krause; Sonja Zimmermann; Stefan Kaulfuss; Kerstin Gleier
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Genetic heterogeneity of Shiga toxin-producing Escherichia coli strains isolated in Sao Paulo, Brazil, from 1976 through 2003, as revealed by pulsed-field gel electrophoresis.

Authors:  Tânia Mara I Vaz; Kinue Irino; Lucilia S Nishimura; Maria Cecília Cergole-Novella; Beatriz Ernestina C Guth
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Luminescence based enzyme-labeled phage (Phazyme) assays for rapid detection of Shiga toxin producing Escherichia coli serogroups.

Authors:  John D Willford; Bledar Bisha; Kyle E Bolenbaugh; Lawrence D Goodridge
Journal:  Bacteriophage       Date:  2011-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.